Lipella Pharmaceuticals Inc. (LIPO) stock
Close on Oct 19, 2026Market cap $2.27KP/E –Yield –
Earnings
Lipella Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Lipella Pharmaceuticals's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q1 FY2023ended Mar 31, 2023 | Apr 3, 2023during market hours | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Lipella Pharmaceuticals has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Lipella Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Lipella Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- News
- News
- News
- News
- News
- Update
See a number that looks wrong?